Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lieber

Showing results (501-510 of 556) with videos related to

Pageof 56
Sort By:
Cancer|July 1, 1992
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsH Zincke, E J Bergstralh, J J Larson-Keller, et al.
Cancer Research|March 4, 1998
A molecular cytogenetic analysis of 7q31 in prostate cancerR B Jenkins, J Qian, H K Lee, et al.
The Journal of Sexual Medicine|July 16, 2008
The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among MenNaomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
Nature Nanotechnology|June 9, 2015
Syringe-injectable electronicsJia Liu, Tian-Ming Fu, Zengguang Cheng, et al.
BJU International|January 12, 2012
Nocturia is associated with an increased risk of coronary heart disease and deathDeborah J Lightner, Amy E Krambeck, Debra J Jacobson, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
International Journal of Cardiology|April 17, 2013
MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcomeA W Leber, W Eichinger, J Rieber, et al.
Urology|October 22, 2013
Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health StudyAruna V Sarma, Jennifer L St Sauver, Debra J Jacobson, et al.
Urology|March 30, 1999
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study GroupC G Roehrborn, J D McConnell, M Lieber, et al.
Journal of Virology|January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virusJenny Wong, Tahirah Moore, Devin Lewis, et al.
Pageof 56

Showing results (501-510 of 556) with videos related to

Sort By:
Pageof 56
Cancer|July 1, 1992
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsH Zincke, E J Bergstralh, J J Larson-Keller, et al.
Cancer Research|March 4, 1998
A molecular cytogenetic analysis of 7q31 in prostate cancerR B Jenkins, J Qian, H K Lee, et al.
The Journal of Sexual Medicine|July 16, 2008
The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among MenNaomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
Nature Nanotechnology|June 9, 2015
Syringe-injectable electronicsJia Liu, Tian-Ming Fu, Zengguang Cheng, et al.
BJU International|January 12, 2012
Nocturia is associated with an increased risk of coronary heart disease and deathDeborah J Lightner, Amy E Krambeck, Debra J Jacobson, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
International Journal of Cardiology|April 17, 2013
MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcomeA W Leber, W Eichinger, J Rieber, et al.
Urology|October 22, 2013
Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health StudyAruna V Sarma, Jennifer L St Sauver, Debra J Jacobson, et al.
Urology|March 30, 1999
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study GroupC G Roehrborn, J D McConnell, M Lieber, et al.
Journal of Virology|January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virusJenny Wong, Tahirah Moore, Devin Lewis, et al.
Pageof 56